Subtopic Deep Dive
VEGF-C signaling in lymphangiogenesis
Research Guide
What is VEGF-C signaling in lymphangiogenesis?
VEGF-C signaling in lymphangiogenesis refers to the process where VEGF-C binds VEGFR-3 on lymphatic endothelial cells, activating downstream pathways that drive lymphatic vessel sprouting and proliferation.
VEGF-C activates VEGFR-3 to promote lymphangiogenesis essential for development and pathology (Shibuya and Claesson-Welsh, 2005; 1051 citations). This signaling induces lymphatic endothelial cell proliferation and migration via PI3K/Akt and MAPK pathways (Koch and Claesson-Welsh, 2012; 879 citations). Over 10 key papers from 2001-2014 detail its role in tumor metastasis and inflammation, with Shibuya's work cited over 1000 times.
Why It Matters
VEGF-C signaling drives tumor lymphangiogenesis, enabling cancer metastasis, as shown in Mandriota et al. (2001; 971 citations) where VEGF-C overexpression promoted tumor spread in mice. Therapeutic inhibition of VEGFR-3 reduces lymphedema and metastasis in models (Mäkinen et al., 2001; 767 citations). Macrophages expressing VEGF-C contribute to peritumoral lymphangiogenesis (Schoppmann et al., 2002; 777 citations), making it a target for anti-cancer drugs blocking lymphatic spread.
Key Research Challenges
VEGFR-3 Downstream Pathway Mapping
Dissecting precise PI3K/Akt and MAPK activation by VEGF-C remains incomplete due to ligand processing variability. Shibuya and Claesson-Welsh (2005) outlined core transduction but gaps persist in isoform-specific effects. Koch and Claesson-Welsh (2012) highlight context-dependent signaling in lymphatics.
Therapeutic VEGFR-3 Inhibition Specificity
Soluble VEGFR-3 blocks lymphangiogenesis but risks off-target blood vessel effects (Mäkinen et al., 2001). Balancing anti-lymphangiogenic benefits with hemangiogenesis disruption challenges drug design. Veikkola et al. (2001) showed VEGFR-3 sufficiency for lymphangiogenesis in transgenics.
Macrophage-VEGF-C Crosstalk Mechanisms
Tumor-associated macrophages secrete VEGF-C to induce peritumoral lymphatics, but recruitment signals are unclear (Schoppmann et al., 2002). Cursiefen et al. (2004) demonstrated VEGF-A recruits macrophages for lymphangiogenesis. Riabov et al. (2014) review TAM roles in both angiogenesis and lymphangiogenesis.
Essential Papers
Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis
Masabumi Shibuya, Lena Claesson‐Welsh · 2005 · Experimental Cell Research · 1.1K citations
VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment
Claus Cursiefen, Lu Chen, Leonardo P. Borges et al. · 2004 · Journal of Clinical Investigation · 1.0K citations
Lymphangiogenesis, an important initial step in tumor metastasis and transplant sensitization, is mediated by the action of VEGF-C and -D on VEGFR3. In contrast, VEGF-A binds VEGFR1 and VEGFR2 and ...
Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis
Stefano J. Mandriota · 2001 · The EMBO Journal · 971 citations
An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype
Jeffrey T. Wigle · 2002 · The EMBO Journal · 932 citations
Signal Transduction by Vascular Endothelial Growth Factor Receptors
Siegfried Koch, Lena Claesson‐Welsh · 2012 · Cold Spring Harbor Perspectives in Medicine · 879 citations
Vascular endothelial growth factors (VEGFs) are master regulators of vascular development and of blood and lymphatic vessel function during health and disease in the adult. It is therefore importan...
Tumor-Associated Macrophages Express Lymphatic Endothelial Growth Factors and Are Related to Peritumoral Lymphangiogenesis
Sebastian F. Schoppmann, Peter Birner, Johannes Stöckl et al. · 2002 · American Journal Of Pathology · 777 citations
Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3
Taija Mäkinen, Lotta Jussila, Tanja Veikkola et al. · 2001 · Nature Medicine · 767 citations
Reading Guide
Foundational Papers
Start with Shibuya and Claesson-Welsh (2005; 1051 citations) for VEGF receptor basics, then Mandriota (2001; 971 citations) for metastasis links, and Koch and Claesson-Welsh (2012; 879 citations) for detailed transduction mechanisms.
Recent Advances
Riabov et al. (2014; 609 citations) on tumor macrophage roles; builds on Schoppmann (2002) for peritumoral lymphatics.
Core Methods
Transgenic overexpression (Veikkola 2001; Mäkinen 2001), macrophage depletion (Cursiefen 2004; Maruyama 2005), and Prox1 staining for lymphatic identity (Wigle 2002).
How PapersFlow Helps You Research VEGF-C signaling in lymphangiogenesis
Discover & Search
PapersFlow's Research Agent uses searchPapers('VEGF-C VEGFR-3 lymphangiogenesis') to retrieve 250M+ OpenAlex papers, including Shibuya and Claesson-Welsh (2005; 1051 citations), then citationGraph to map downstream works like Mäkinen (2001). exaSearch uncovers obscure macrophage-VEGF-C links, while findSimilarPapers expands from Mandriota (2001) to 50+ metastasis studies.
Analyze & Verify
Analysis Agent employs readPaperContent on Cursiefen (2004) to extract VEGF-A/macrophage data, verifies claims via CoVe against Koch (2012), and runs PythonAnalysis to quantify signaling pathway overlaps using pandas on extracted kinase mentions. GRADE grading scores evidence strength for therapeutic claims from Mäkinen (2001), with statistical verification of citation networks.
Synthesize & Write
Synthesis Agent detects gaps in macrophage-VEGF-C therapeutic modulation via contradiction flagging across Schoppmann (2002) and Riabov (2014), while Writing Agent uses latexEditText for pathway diagrams, latexSyncCitations to integrate 20+ refs, and latexCompile for publication-ready reviews. exportMermaid generates VEGFR-3 signaling flowcharts from literature synthesis.
Use Cases
"Analyze VEGF-C dosage effects on lymphatic sprouting from Mäkinen transgenic models"
Analysis Agent → readPaperContent(Mäkinen 2001) → runPythonAnalysis(dose-response curve fitting with matplotlib on extracted data) → statistical p-values and proliferation plots.
"Draft review section on VEGFR-3 inhibition for cancer lymphangiogenesis"
Synthesis Agent → gap detection(Veikkola 2001 + Mandriota 2001) → Writing Agent → latexEditText(draft text) → latexSyncCitations(10 refs) → latexCompile(PDF with figures).
"Find code for VEGFR-3 signaling simulations in lymphangiogenesis papers"
Research Agent → searchPapers(VEGF-C simulation) → Code Discovery (paperExtractUrls → paperFindGithubRepo → githubRepoInspect) → runnable Python models for pathway dynamics.
Automated Workflows
Deep Research workflow conducts systematic review: searchPapers(50+ VEGF-C papers) → citationGraph → DeepScan(7-step verification with CoVe checkpoints) → structured report on signaling consensus. Theorizer generates hypotheses on macrophage-VEGF-C feedback from Riabov (2014) + Schoppmann (2002). DeepScan analyzes Shibuya (2005) for pathway gaps with GRADE scoring.
Frequently Asked Questions
What defines VEGF-C signaling in lymphangiogenesis?
VEGF-C binds VEGFR-3 on lymphatic endothelial cells, triggering PI3K/Akt and MAPK pathways for vessel sprouting (Shibuya and Claesson-Welsh, 2005).
What are key methods studying this pathway?
Transgenic mice overexpressing VEGF-C or soluble VEGFR-3 model lymphangiogenesis (Mäkinen et al., 2001; Veikkola et al., 2001); immunostaining detects lymphatic markers post-stimulation.
What are seminal papers?
Shibuya and Claesson-Welsh (2005; 1051 citations) on VEGF receptor transduction; Mandriota (2001; 971 citations) on tumor metastasis via VEGF-C.
What open problems exist?
Isoform-specific VEGF-C effects on VEGFR-3 and macrophage recruitment precision remain unresolved (Cursiefen et al., 2004; Riabov et al., 2014).
Research Lymphatic System and Diseases with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching VEGF-C signaling in lymphangiogenesis with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Lymphatic System and Diseases Research Guide